Volume 17, Issue 3, Pages (March 2013)

Slides:



Advertisements
Similar presentations
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
Advertisements

Volume 6, Issue 8, Pages (August 2017)
Volume 10, Issue 4, Pages (October 2009)
Volume 14, Issue 4, Pages (October 2011)
Volume 11, Issue 8, Pages (May 2015)
Volume 3, Issue 5, Pages (May 2006)
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 24, Issue 6, Pages (December 2016)
Come on BAIBA Light My Fire
Volume 26, Issue 4, Pages e3 (October 2017)
Volume 10, Issue 4, Pages (October 2009)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 6, Issue 3, Pages (September 2007)
Volume 17, Issue 5, Pages (May 2013)
Volume 17, Issue 4, Pages (April 2013)
Volume 9, Issue 4, Pages (April 2009)
Volume 18, Issue 1, Pages (July 2013)
Volume 21, Issue 11, Pages (December 2017)
Volume 23, Issue 1, Pages (January 2016)
Volume 14, Issue 3, Pages (September 2011)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 17, Issue 5, Pages (May 2013)
Volume 25, Issue 2, Pages (February 2017)
Volume 3, Issue 3, Pages (March 2006)
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Volume 14, Issue 2, Pages (August 2011)
Volume 15, Issue 3, Pages (March 2008)
Volume 16, Issue 7, Pages (August 2016)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 17, Issue 5, Pages (May 2013)
Volume 16, Issue 2, Pages (August 2012)
Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 23, Issue 6, Pages (June 2016)
Volume 16, Issue 4, Pages (October 2012)
Volume 9, Issue 5, Pages (May 2009)
Volume 21, Issue 5, Pages (May 2015)
Volume 6, Issue 4, Pages (October 2007)
Volume 6, Issue 4, Pages (October 2007)
Volume 10, Issue 5, Pages (November 2009)
Volume 10, Issue 1, Pages (July 2009)
Volume 8, Issue 4, Pages (October 2008)
Volume 25, Issue 4, Pages e4 (April 2017)
ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion
Volume 5, Issue 5, Pages (May 2007)
Volume 22, Issue 2, Pages (August 2015)
Volume 15, Issue 5, Pages (May 2012)
Volume 6, Issue 3, Pages (September 2007)
Volume 6, Issue 5, Pages (November 2007)
Volume 2, Issue 2, Pages (August 2005)
Volume 14, Issue 4, Pages (October 2011)
Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis  Sarah H. Bates, Rohit N. Kulkarni, Matthew.
Volume 8, Issue 5, Pages (November 2008)
Volume 14, Issue 5, Pages (November 2011)
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Volume 14, Issue 2, Pages (August 2011)
Volume 22, Issue 2, Pages (August 2015)
Volume 9, Issue 6, Pages (June 2009)
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Volume 6, Issue 4, Pages (October 2007)
Lipin, a lipodystrophy and obesity gene
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 4, Issue 5, Pages (November 2006)
Clémence Blouet, Hiraku Ono, Gary J. Schwartz  Cell Metabolism 
Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation  Jieun Lee, Jessica M. Ellis, Michael J.
Volume 24, Issue 6, Pages (December 2016)
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Volume 16, Issue 3, Pages (September 2012)
Volume 6, Issue 6, Pages (December 2007)
Presentation transcript:

Volume 17, Issue 3, Pages 456-462 (March 2013) Duration of Rapamycin Treatment Has Differential Effects on Metabolism in Mice  Yimin Fang, Reyhan Westbrook, Cristal Hill, Ravneet K. Boparai, Oge Arum, Adam Spong, Feiya Wang, Martin A. Javors, Jie Chen, Liou Y. Sun, Andrzej Bartke  Cell Metabolism  Volume 17, Issue 3, Pages 456-462 (March 2013) DOI: 10.1016/j.cmet.2013.02.008 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Body Characteristics Alter with Duration of Rapamycin Treatment (A) Relative total fat mass [absolute value (g) / body weight (g)] × 100. Total fat includes subcutaneous fat from the thighs, a pair of perigonadal (visceral) depots, a pair of perinephric depots, and interscapular brown fat. (B) Relative mass of the pancreas. (C) Relative mass of the liver. (D) Body weight. (E) Relative total lean mass [absolute value (g)/body weight (g)] × 100. Total lean mass is estimated as follows: lean mass = body weight – total fat mass. (F) Time course of body weight measured over 20 weeks of rapamycin treatment. (G) Time course of food consumption over 19 weeks of rapamycin treatment. Data are means ± SEM (n = 8–16 for control, n = 9–16 for rapamycin). p values were calculated between the rapamycin-treated and control groups at each time point independently. The error bars represent the SEM. ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001. See also Figure S1. Cell Metabolism 2013 17, 456-462DOI: (10.1016/j.cmet.2013.02.008) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Insulin Signaling and Glucose Homeostasis Switch from Insulin Resistant State with Short Rapamycin Treatment to Insulin Sensitive State with Prolonged Rapamycin Treatment (A) Plasma insulin levels. (B) Fasted glucose levels. (C) Homeostatic model for assessment of insulin resistance (HOMA-IR). HOMA-IR = (FPI × FPG) / 22.5, where FPI is fasted plasma insulin and FPG is fasted plasma glucose. Plasma and fasted glucose values were collected at sacrifice. (D, F, and H) Glucose tolerance test (GTT). Sixteen-hour-fasted mice underwent GTT by intraperitoneal (i.p.) injection with 1 g glucose per kg of BW. (E, G, and I) Insulin tolerance test (ITT). Mice were i.p. injected with 1 IU porcine insulin per kg of BW. Data are mean ± SEM (n = 8–16 for control, n = 9–16 for rapamycin). p values were calculated between the rapamycin-treated and control groups at each time point independently. The error bars represent the SEM.∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001. See also Figure S2 and Table S1. Cell Metabolism 2013 17, 456-462DOI: (10.1016/j.cmet.2013.02.008) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Lipid Profile, Oxygen Consumption, and Total Ketone Body Production Chang after Different Lengths of Rapamycin Treatment (A) Plasma glycerol levels. (B) Plasma NEFA levels. (C) Plasma triglycerides levels. For plasma chemical analysis, mice were fasted for 16 hr, and thusly collected plasma was subjected to the assays. (D–F) Oxygen consumption VO2 (ml/kg/min) measured via indirect calorimetry (AccuScan Instruments, Columbus, OH) after 2 weeks (D), 6 weeks (E), or 20 weeks (F) of rapamycin treatment. Data are mean ± SEM (n = 8 for control or rapamycin). (G) Plasma total ketone bodies. Mice were fasted for 16 hr, and plasma total ketone bodies were measured with total ketone body kits (Wako, Richmond, VA). Data are mean ± SEM (n = 8–16 for control, n = 9–16 for rapamycin). The error bars represent the SEM.∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001. Cell Metabolism 2013 17, 456-462DOI: (10.1016/j.cmet.2013.02.008) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Effects of Different Duration of Rapamycin Treatment on the Blood Levels of Rapamycin and Phosphorylation of S6 in the Liver (A) Western blots of S6 and phosphorylation of S6 at S240/244. Western blots are representative of three independent experiments. Each treatment includes six samples from six individual animals. (B) Quantification of the western blots. Data are means ± SEM (n = 6). (C) Blood levels of rapamycin. Data are means ± SEM (n = 4–6). p values were calculated between the rapamycin-treated and control groups at each time point independently. Different letters represent p ≤ 0.05. The error bars represent the SEM. See also Figures S3 and S4. Cell Metabolism 2013 17, 456-462DOI: (10.1016/j.cmet.2013.02.008) Copyright © 2013 Elsevier Inc. Terms and Conditions